Some patients with Type 2 diabetes taking drugs to lower blood sugar may experience a greater drop than is healthy for them even though their disease may not be under control, according to a new study.
Boulder Brands, Inc. announced it had acquired 80% of GlucoBrands, owner of Level Life Foods. Based in Colorado, Level is a growing company, approaching $1 million in sales that provides products to help in the daily management of diabetes.
The Indian generic drug maker announced the approval of repaglinide tablets in the 1-mg and 2-mg strengths, which are used in combination with diet and exercise to improve blood-sugar control in patients with Type 2 diabetes.
A new study from the University of Iowa confirms what researchers at the U.S. Centers for Disease Control and Prevention reported last year: that the number and severity of lower-limb amputations among American diabetics is down “dramatically” in recent years. The latest findings, reported by Drug Store News Monday, show a nearly 29% overall drop in lower-limb amputations among Medicare patients with diabetes between 2000 and 2010. And there was a “striking” decrease in the severity of such amputations, as well, according to study author Phinit Phisitkul.
Bayer HealthCare, makers of the Contour Next portfolio of blood-glucose meters, and dLife Healthcare Solutions, a diabetes behavior change solution, have created and are working together to offer Eat Well, Test Well, a six-week food and nutrition program for people with diabetes available at no charge.